Yuqiu Jiang

3.4k total citations · 1 hit paper
26 papers, 2.4k citations indexed

About

Yuqiu Jiang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Yuqiu Jiang has authored 26 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 12 papers in Cancer Research. Recurrent topics in Yuqiu Jiang's work include Cancer Genomics and Diagnostics (11 papers), Lung Cancer Treatments and Mutations (7 papers) and Advanced Breast Cancer Therapies (6 papers). Yuqiu Jiang is often cited by papers focused on Cancer Genomics and Diagnostics (11 papers), Lung Cancer Treatments and Mutations (7 papers) and Advanced Breast Cancer Therapies (6 papers). Yuqiu Jiang collaborates with scholars based in United States, Germany and Italy. Yuqiu Jiang's co-authors include Cynthia Huang Bartlett, María Koehler, Massimo Cristofanilli, Sherene Loi, Ke Zhang, Dennis J. Slamon, Nicholas C. Turner, Marco Colleoni, Norikazu Masuda and Hiroji Iwata and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Yuqiu Jiang

26 papers receiving 2.4k citations

Hit Papers

Fulvestrant plus palbociclib versus fulvestrant plus plac... 2016 2026 2019 2022 2016 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial
    2016 1.2k citations Massimo Cristofanilli, Nicholas C. Turner et al. The Lancet Oncology profile →

Peers

Yuqiu Jiang
Judy Dering United States
Ilenia Migliaccio Italy
Amrita Desai United States
Peter Kabos United States
Eva Ciruelos Spain
Dylan Conklin United States
Mónica V. Estrada United States
Ben O’Leary United Kingdom
Luigi Formisano Italy
Ondrej Kalous United States
Judy Dering United States
Yuqiu Jiang
Citations per year, relative to Yuqiu Jiang Yuqiu Jiang (= 1×) peers Judy Dering

Countries citing papers authored by Yuqiu Jiang

Since Specialization
Citations

This map shows the geographic impact of Yuqiu Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuqiu Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuqiu Jiang more than expected).

Fields of papers citing papers by Yuqiu Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuqiu Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuqiu Jiang. The network helps show where Yuqiu Jiang may publish in the future.

Co-authorship network of co-authors of Yuqiu Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Yuqiu Jiang. A scholar is included among the top collaborators of Yuqiu Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuqiu Jiang. Yuqiu Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ho, Hsiang‐Ling, Yuqiu Jiang, Chi‐Lu Chiang, et al.. (2022). Efficacy of liquid biopsy for disease monitoring and early prediction of tumor progression in EGFR mutation-positive non-small cell lung cancer. PLoS ONE. 17(4). e0267362–e0267362. 8 indexed citations
2.
Zou, Wei, Stephanie J. Yaung, Marcus Ballinger, et al.. (2021). ctDNA Predicts Overall Survival in Patients With NSCLC Treated With PD-L1 Blockade or With Chemotherapy. JCO Precision Oncology. 5(5). 827–838. 35 indexed citations
3.
Ju, Christine, Bernd Hinzmann, Stephanie J. Yaung, et al.. (2020). Disease monitoring and TKI resistance mutations of EGFR mutation-positive NSCLC patients via circulating tumor DNA.. Journal of Clinical Oncology. 38(15_suppl). e21627–e21627. 1 indexed citations
4.
Yaung, Stephanie J., Fergal Casey, Maureen Peterson, et al.. (2019). Evaluation of clonal hematopoiesis in late stage NSCLC using a next-generation sequencing panel targeting cancer genes.. Journal of Clinical Oncology. 37(15_suppl). 9050–9050. 1 indexed citations
5.
Chiang, Chi‐Lu, Yuqiu Jiang, K. S. Sharma, et al.. (2019). Disease monitoring of EGFR mutation-positive NSCLC patients via circulating tumour DNA. Annals of Oncology. 30. v643–v643. 1 indexed citations
6.
Cristofanilli, Massimo, Nicholas C. Turner, Igor Bondarenko, et al.. (2016). Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial. The Lancet Oncology. 17(4). 425–439. 1247 indexed citations breakdown →
7.
8.
Turner, Nicholas C., Yuqiu Jiang, Ben O’Leary, et al.. (2016). Efficacy of palbociclib plus fulvestrant (P+F) in patients (pts) with metastatic breast cancer (MBC) and ESR1 mutations (mus) in circulating tumor DNA (ctDNA).. Journal of Clinical Oncology. 34(15_suppl). 512–512. 14 indexed citations
9.
DeMichele, Angela, María Koehler, Yuqiu Jiang, et al.. (2016). Abstract P4-13-04: Upregulation of cell cycle pathway genes without loss of RB1 contributes to acquired resistance to single-agent treatment with palbociclib in breast cancer. Cancer Research. 76(4_Supplement). P4–13. 3 indexed citations
10.
11.
Kani, Kian, Paymaneh D. Malihi, Yuqiu Jiang, et al.. (2012). Anterior gradient 2 (AGR2): Blood‐based biomarker elevated in metastatic prostate cancer associated with the neuroendocrine phenotype. The Prostate. 73(3). 306–315. 52 indexed citations
12.
Mostert, Bianca, Yuqiu Jiang, Anieta M. Sieuwerts, et al.. (2012). KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue. International Journal of Cancer. 133(1). 130–141. 110 indexed citations
13.
Jiang, Yuqiu & Mu Wang. (2010). Personalized Medicine in Oncology: Tailoring the Right Drug to The Right Patient. Biomarkers in Medicine. 4(4). 523–533. 25 indexed citations
14.
Jiang, Yuqiu, John F. Palma, David B. Agus, Yixin Wang, & Mitchell E. Gross. (2010). Detection of Androgen Receptor Mutations in Circulating Tumor Cells in Castration-Resistant Prostate Cancer. Clinical Chemistry. 56(9). 1492–1495. 105 indexed citations
15.
Jiang, Yuqiu, Graham Casey, Ian C. Lavery, et al.. (2008). Development of a Clinically Feasible Molecular Assay to Predict Recurrence of Stage II Colon Cancer. Journal of Molecular Diagnostics. 10(4). 346–354. 45 indexed citations
16.
Zhang, Shuang, Wenyue Ji, Yuqiu Jiang, et al.. (2006). [The relation of metastasis and prognosis with transforming growth factor-beta1 and E-cadherin expression in supraglottic larynx squamous cell carcinoma].. PubMed. 20(12). 534–7. 1 indexed citations
17.
Talantov, Dmitri, Abhijit Mazumder, Jack X. Yu, et al.. (2005). Novel Genes Associated with Malignant Melanoma but not Benign Melanocytic Lesions. Clinical Cancer Research. 11(20). 7234–7242. 409 indexed citations
18.
Yang, Fei, John A. Foekens, Jingxue Yu, et al.. (2005). Laser microdissection and microarray analysis of breast tumors reveal ER-α related genes and pathways. Oncogene. 25(9). 1413–1419. 57 indexed citations
19.
Stolk, John A., Yuqiu Jiang, Craig H. Day, et al.. (2004). P704P, P712P, and P775P: A genomic cluster of prostate‐specific genes. The Prostate. 60(3). 214–226. 2 indexed citations
20.
Jiang, Yuqiu, Susan L. Harlocker, David A Molesh, et al.. (2002). Discovery of differentially expressed genes in human breast cancer using subtracted cDNA libraries and cDNA microarrays. Oncogene. 21(14). 2270–2282. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Judy Dering Breakdown of academic impact, for papers by Ilenia Migliaccio Breakdown of academic impact, for papers by Amrita Desai Breakdown of academic impact, for papers by Peter Kabos Breakdown of academic impact, for papers by Eva Ciruelos Breakdown of academic impact, for papers by Dylan Conklin Breakdown of academic impact, for papers by Mónica V. Estrada Breakdown of academic impact, for papers by Ben O’Leary Breakdown of academic impact, for papers by Luigi Formisano Breakdown of academic impact, for papers by Ondrej Kalous
Rankless by CCL
2026